Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1990-7-19
pubmed:abstractText
12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid [12(R)-HETE] is one of the major arachidonate metabolites of the corneal epithelial cytochrome P450 system. We studied its inhibitory effect on different preparations of (Na(+)-K+)ATPase. 12(R)-HETE had no effect on ATPase activity in the absence of Na+ and K+. However, it inhibited ouabain-sensitive (Na(+)-K+)ATPase obtained from bovine corneal epithelium, rat kidney and rat heart ventricle in a concentration-dependent manner with an IC50 of 10(-6) M. Its enantiomer, 12(S)-HETE, was inactive at 10(-7) M and 10(-6) M, but it inhibited (Na(+)-K+)ATPase at higher doses, an effect also seen with arachidonic acid. 12(R)-HETE as an endogenous metabolite of arachidonic acid may modulate physiological and pathophysiological processes by affecting (Na(+)-K+)ATPase activities in vivo.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0006-2952
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1971-4
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Inhibition of renal, cardiac and corneal (Na(+)-K+)ATPase by 12(R)-hydroxyeicosatetraenoic acid.
pubmed:affiliation
Department of Pharmacology, New York Medical College, Valhalla 10595.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't